Open access to the CAS BioFinder platform

From October 15, 2025 to December 14, 2025 Test access to the platform is open CAS BioFinder.

Link to resource https://biofinder.cas.org/

CAS BioFinder Discovery Platform – scientific and information platform created Chemical Abstracts Service (CAS),division American Chemical Society (ACS), designed to accelerate the early-stage drug development process by combining carefully curated data with predictive analytics based on artificial intelligence (AI) technologies.

Key platform features CAS BioFinder:

1. Comprehensive data integration.

2. AI-based predictive models.

3. Tools for convenient work.

4. Expertly verified data.

Platform CAS BioFinder will be useful for specialists involved in drug development, allowing them to speed up the process of identifying potential targets, studying molecular structures and assessing their safety, revealing hidden interactions between biomarkers (for example, BRCA) and diseases, and evaluating clinical trial data to confirm the feasibility of selected targets.

Access is provided via IP addresses and through WI-FI NGU.

Registration on the platform using the NSU CORPORATE email address is required.

You can log in using your existing login CAS SciFinder.